CCL4 and tuberculosis: CCL4 is overexpressed in lung tissues of mice with TB and in patients with late-stage TB [25], suggesting that the significant decrease in CCL4 expression observed in individuals with LTBI after INH treatment might be associated with a decreased risk of developing active TB and could, therefore, be useful as a biomarker of treatment efficacy.